Hematopoietic and Lymphoid Cell Neoplasm

Showing 26 - 50 of 153

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

Recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +33 more
  • Informational Intervention
  • +4 more
  • Los Angeles, California
  • +4 more
Dec 14, 2022

Hematopoietic and Lymphoid Cell Tumor, Metastatic Malignant Solid Tumor Trial in United States (External Beam Radiation Therapy,

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • External Beam Radiation Therapy
  • +2 more
  • Conroe, Texas
  • +4 more
Dec 12, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +11 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Hematopoietic and Lymphoid Cell Tumor Trial in United States (Best Practice and Internet site with links to existing resources,

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Best Practice and Internet site with links to existing resources
  • +2 more
  • Tampa, Florida
  • +14 more
Dec 5, 2022

Identifying Malnutrition in Older Cancer Participants

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Comprehensive Geriatric Assessment
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Memphis, Seattle (Behavioral Intervention, Survey

Enrolling by invitation
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Behavioral Intervention
  • Survey Administration
  • Memphis, Tennessee
  • +1 more
Nov 18, 2022

l Empathy of Healthcare Practitioners From Department of

Active, not recruiting
  • COVID-19 Infection
  • +2 more
  • Best Practice
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 8, 2022

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +5 more
Nov 1, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Sleep Disorder Trial in Houston (other, drug, procedure)

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Counseling
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid

Recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • +11 more
  • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 24, 2022

COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients

Recruiting
  • COVID-19 Infection
  • +2 more
  • Quality-of-Life Assessment
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (Behavioral Intervention, Interview,

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Behavioral Intervention
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2022

Chemo-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (drug,

Recruiting
  • Chemotherapy-Induced Peripheral Neuropathy
  • +2 more
  • Houston, Texas
  • +1 more
Oct 6, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Preliminary Testing of MD Anderson Symptom Inventory

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Interview
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Solid Tumor Trial in Orland Park, Seattle (Nozin, Best Practice)

Suspended
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Orland Park, Illinois
  • +1 more
Sep 20, 2022

Distress Associated With Coronavirus Disease 2019 and Telehealth

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Survey Administration
  • Houston, Texas
    M D Anderson Cancer Center
Sep 16, 2022

Interviews, Screening, Healthcare Workers Trial in Houston (First Interview, Second Interview, 8-week multicomponent

Recruiting
  • Anxiety Disorder
  • +2 more
  • Behavioral Intervention
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Hematopoietic and Lymphoid Cell Tumor Trial in Seattle (Nutritional Supplement Drink, Standard of Care Nutritional Support,

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Nutritional Supplement Drink
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Tumor, Lynch Syndrome Trial in Canada,

Withdrawn
  • Constitutional Mismatch Repair Deficiency Syndrome
  • +11 more
  • Biospecimen Collection
  • +2 more
  • Palo Alto, California
  • +8 more
Sep 9, 2022

Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (radiation, procedure, drug)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Total-Body Irradiation
  • +5 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 7, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Portland (Survey Administration, Virtual Reality Game,

Completed
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Survey Administration
  • +2 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 4, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

Terminated
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +12 more
  • Laboratory Biomarker Analysis
  • ROR1 CAR-specific Autologous T-Lymphocytes
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 11, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +37 more
  • Birmingham, Alabama
  • +171 more
Aug 24, 2022